Alzheimer's Disease Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People aged between 50 and 85 years old, either male or female.
- People who have completed at least primary school education, have normal hearing, vision, and speech, and use Mandarin Chinese as their everyday language.
- People who have been diagnosed with Alzheimer's disease (AD) or mild cognitive impairment (MCI) according to specific diagnostic criteria used by the trial.
- People whose scores on two standard memory and thinking tests (called MMSE and CDR) fall within a certain range — MMSE score between 10 and 28, and CDR score of 2 or below.
- People whose patient or family member agrees to sign an informed consent form.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have a neurological condition that could affect brain function, such as depression, brain tumours, Parkinson's disease, encephalitis, epilepsy, multiple sclerosis, brain injury, or similar conditions.
- People who have a medical condition affecting other parts of the body that could impact memory or thinking, such as liver or kidney problems, thyroid issues, severe anaemia, vitamin B12 or folic acid deficiency, syphilis, HIV, or alcohol or drug misuse.
- People who have a condition that would prevent them from completing the trial's tests and examinations.
- People who are unable to have an MRI (magnetic resonance imaging) scan.
- People who have an intellectual disability or neurodevelopmental condition.
- People who are unwilling to sign an informed consent form.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Huayan Liu, the first affiliated hospital of China medical university, neurology department
Phone: +86 13609831417
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Primary endpoints
The diagnostic efficiency of multimodal deep learning diagnostic strategy
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.